Delivery Order SPE2DR25D1021-SPE2DR26FNN3X
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Micardis HCT 80-12.5 mg tablets in unit dose packaging (30-count), with a contract ceiling value of $3,302.35. This firm fixed-price delivery order is scheduled for completion by December 9, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging) with a contract value of $2,342.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 5, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Micardis HCT 80-25 mg tablet unit dose packages (30-count) with a ceiling value of $2,217.60. This is a firm fixed-price delivery order with an ultimate completion date of October 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packages of 30 units. This firm fixed-price delivery order, valued at $1,889.91, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a $1,207.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging (30 count). The contract, with an ultimate completion date of December 10, 2025, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This award was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $6,583.92 to supply Micardis HCT 80-25 mg tablets in unit dose packaging of 30 units. The contract, which is non-competitive and firm fixed price, was awarded on November 10, 2025, with an ultimate completion date of November 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $27,546.64 to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Micardis HCT 80-25 mg tablets (unit dose, 30-count packages). This is a firm fixed-price contract with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 3, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packaging of 30 units. This $1,750.64 firm fixed-price delivery order has an ultimate completion date of November 28, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract vehicle supporting federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a $2,599.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Micardis HCT 40-12.5 mg tablet unit dose packs (30 count). This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Micardis HCT 80-25 mg tablets (30-count unit dose packaging) with a ceiling value of $2,783.91. This firm fixed-price delivery order is scheduled for completion by July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating open competitive procurement. This delivery order...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNN3XDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Micardis HCT 80-25 mg tablets in unit dose packages of 30 units, with a ceiling value of $1,385.99. This is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen Drug Corp utilizes the DLA Troop Support Medical IDC to supply a broad range of pharmaceutical products to military and veteran healthcare programs. The Micardis HCT delivery represents the company's continued role as a critical vendor within DLA's Medical Supply Chain, providing both brand-name and generic medications across multiple therapeutic domains. DLA's Troop Support Medical procurement strategy leverages multiple pharmaceutical prime vendors to ensure global supply chain resilience and competitive pricing for essential medications supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/23/25 |